Kala Bio Inc (KALA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 63,636 | 70,495 | 52,393 | 42,569 | 65,170 |
| Marketable Securities | N/A | N/A | N/A | 2,449 | 4,992 |
| Receivables | N/A | N/A | 190 | 13,822 | 13,020 |
| Inventories | N/A | N/A | N/A | 25 | 10,531 |
| Other current assets | 5,355 | 7,595 | 9,513 | 22,507 | 0 |
| TOTAL | $71,344 | $85,942 | $84,672 | $83,515 | $98,255 |
| Non-Current Assets | |||||
| PPE Net | 504 | 400 | 517 | 891 | 2,704 |
| Other Non-Current Assets | 378 | 478 | 509 | 570 | 10,615 |
| TOTAL | $882 | $878 | $1,026 | $1,461 | $13,319 |
| Total Assets | $72,226 | $86,820 | $85,698 | $84,976 | $111,574 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 9,741 | 4,085 | 3,991 | 4,676 |
| Accounts payable and accrued liabilities | 997 | 2,832 | 7,348 | 10,542 | 6,218 |
| Accrued Expenses | 5,076 | 8,910 | 25,368 | 18,306 | 21,239 |
| TOTAL | $10,265 | $25,685 | $40,241 | $32,891 | $32,758 |
| Non-Current Liabilities | |||||
| Long Term Debt | 38,500 | 42,161 | 46,425 | 83,639 | 83,363 |
| Deferred Revenues | 4,189 | 4,189 | 3,408 | N/A | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 737 |
| TOTAL | $38,500 | $42,161 | $46,425 | $83,639 | $84,100 |
| Total Liabilities | $48,765 | $67,846 | $86,666 | $116,530 | $116,858 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,349 | 2,025 | 1,518 | 1,464 | 1,452 |
| Common Shares | 2 | 2 | 1 | 73 | 73 |
| Retained earnings | -601,665 | -587,210 | -574,367 | -603,440 | -575,329 |
| Other shareholders' equity | 0 | 0 | 0 | -1 | -2 |
| TOTAL | $23,461 | $18,974 | $-968 | $-31,554 | $-5,284 |
| Total Liabilities And Equity | $72,226 | $86,820 | $85,698 | $84,976 | $111,574 |